Guardion Health Sciences Inc.

01/23/2025 | Press release | Distributed by Public on 01/23/2025 16:17

Termination Notice (Form 15-12G)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 001-38861

GUARDION HEALTH SCIENCES, INC.

(Exact name of registrant as specified in its charter)

2925 Richmond Avenue, Suite 1200

Houston, Texas, 77098

(800) 873-5141

(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

Common Stock, par value $0.001 per share

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)
Rule 12g-4(a)(2)
Rule 12h-3(b)(1)(i)
Rule 12h-3(b)(1)(ii)
Rule 15d-6
Rule 15d-22(b)

Approximate number of holders of record as of the certification or notice date:

Title of Class of Securities Approximate number of holders of record
Common Stock 79

Pursuant to the requirements of the Securities Exchange Act of 1934, GUARDION HEALTH SCIENCES, INC. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date: January 23, 2025 By: /s/ Mark Goldstone
Mark Goldstone, President and Chief Executive Officer